Previous close | 27.48 |
Open | 27.66 |
Bid | 27.45 x 100 |
Ask | 27.64 x 100 |
Day's range | 27.17 - 28.25 |
52-week range | 24.60 - 63.57 |
Volume | |
Avg. volume | 1,583,161 |
Market cap | 3.297B |
Beta (5Y monthly) | 1.89 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Review 10x Genomics' (TXG) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
10x Genomics ( NASDAQ:TXG ) First Quarter 2024 Results Key Financial Results Revenue: US$141.0m (up 5.0% from 1Q 2023...
10x Genomics, Inc. (NASDAQ:TXG) Q1 2024 Earnings Call Transcript April 30, 2024 10x Genomics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day everyone and welcome to the 10x Genomics First Quarter 2024 Earnings Call. Today’s call is […]